Literature DB >> 32547148

Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study.

Roqayeh Aliyari1, Ebrahim Hajizadeh1, Ashraf Aminorroaya2, Farshad Sharifi3, Iraj Kazemi4, Ahmad-Reza Baghestani5.   

Abstract

BACKGROUND: Increase in the prevalence of type 2 diabetic mellitus (T2DM) as a complex disease, its complications, and spread has become a dominant global health threat in recent decades.
OBJECTIVE: The aim of the current study was to investigate the impact of risk factors and transition probability on the development and progression of the late complications of T2DM.
METHODS: This study was an open cohort one which was conducted at Isfahan Endocrine and Metabolism Research Center (IEMRC). The data were collected from 1993 to 2018. The sample size consisted of 2519 adults diagnosed with type 2 diabetes. We applied the homogeneous multistate models including no complication, retinopathy alone, coronary artery disease (CAD), microalbuminuria, retinopathy and CAD, and the final absorbing mortality states.
RESULTS: Based on our results, time-varying hypertension strongly intensified the hazard of transition to mortality in CAD, no complication, CAD and retinopathy, and retinopathy patients by 4.99, 4.09, 3.42, and 2.65 times, respectively. Hypertension seemed to be a potential factor for the transition of microalbuminuria to no complication in diabetic patients. One-unit increase in LDL increased the hazard ratio of transition from CAD, and retinopathy and CAD to mortality by 1.8% and 2.4%, respectively. Moreover, one level increase in time-varying HbA1c increased the hazard ratio of transition to retinopathy and mortality among no complication diabetic patients by 30% and 67%, respectively. One level increase in time-varying HbA1c also intensified the hazard ratio of transition from retinopathy to mortality by 45%. The same level of increase in time-varying HbA1c also intensified the hazard ratio of transition from CAD alone to CAD and retinopathy, and microalbuminuria to retinopathy by 26% and 50%, respectively.
CONCLUSION: In addition to glycemic control, our study indicates that controlling hypertension and hyperlipidemia is more effective in reducing mortality and the diabetic macro- and microvascular complications.
© 2020 Aliyari et al.

Entities:  

Keywords:  CAD; T2DM; diabetics complications; hypertension; microalbuminuria; multistate models; retinopathy; transition probability

Year:  2020        PMID: 32547148      PMCID: PMC7266524          DOI: 10.2147/DMSO.S234563

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  34 in total

Review 1.  The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives.

Authors:  Lei Chen; Dianna J Magliano; Paul Z Zimmet
Journal:  Nat Rev Endocrinol       Date:  2011-11-08       Impact factor: 43.330

2.  Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome.

Authors:  Ronald Goldenberg; Zubin Punthakee
Journal:  Can J Diabetes       Date:  2013-03-26       Impact factor: 4.190

3.  Computation of the asymptotic null distribution of goodness-of-fit tests for multi-state models.

Authors:  Andrew C Titman
Journal:  Lifetime Data Anal       Date:  2009-11-01       Impact factor: 1.588

4.  Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.

Authors:  Mohsen Janghorbani; Masoud Amini
Journal:  Diabetes Res Clin Pract       Date:  2005-04-09       Impact factor: 5.602

5.  Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2.

Authors:  Irini P Chatziralli; Theodoros N Sergentanis; Petros Keryttopoulos; Nikolaos Vatkalis; Antonis Agorastos; Leonidas Papazisis
Journal:  BMC Res Notes       Date:  2010-06-01

6.  Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study.

Authors:  Laura N McEwen; Catherine Kim; Andrew J Karter; Mary N Haan; Debashis Ghosh; Paula M Lantz; Carol M Mangione; Theodore J Thompson; William H Herman
Journal:  Diabetes Care       Date:  2007-04-27       Impact factor: 19.112

7.  Microalbuminuria, is it so important?

Authors:  A Koroshi
Journal:  Hippokratia       Date:  2007-07       Impact factor: 0.471

8.  Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.

Authors:  Samuel Adamsson Eryd; Soffia Gudbjörnsdottir; Karin Manhem; Annika Rosengren; Ann-Marie Svensson; Mervete Miftaraj; Stefan Franzén; Staffan Björck
Journal:  BMJ       Date:  2016-08-04

Review 9.  Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?

Authors:  Aastha Chawla; Rajeev Chawla; Shalini Jaggi
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug

Review 10.  Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.

Authors:  John R Petrie; Tomasz J Guzik; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2017-12-11       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.